Alfred D. Kingsley - 31 Dec 2022 Form 5 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role
Director
Signature
/s/ Grant Harbert, as Attorney-in-Fact
Issuer symbol
LCTX
Transactions as of
31 Dec 2022
Net transactions value
$0
Form type
5
Filing time
14 Feb 2023, 15:16:07 UTC
Previous filing
27 Dec 2022
Next filing
15 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LCTX Common Shares, no par value Gift -25,000 -0.46% 5,430,545 01 Dec 2022 Direct F1
holding LCTX Common Shares, no par value 1,043,346 31 Dec 2022 By Corporation F2
holding LCTX Common Shares, no par value 375,351 31 Dec 2022 By LP F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a gift of 25,000 common shares.
F2 Held by Greenbelt Corporation, of which Mr. Kingsley is an executive officer, director, and controlling shareholder. Mr. Kingsley disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest.
F3 Held by Greenway Partners, LP, of which Mr. Kingsley is the General Partner and has sole voting and dispositive control.